BillionToOne, Inc
Healthcare
BillionToOne is a biotechnology company focused on advancing molecular diagnostics through its proprietary technology, Quantitative Counting Templates (QCTs™). This technology enables the detection and quantification of disease-related DNA at single base-pair resolution, enhancing prenatal screening and oncology testing. BillionToOne offers products like UNITY Screen™ for prenatal screening and Northstar Select™ for oncology therapy guidance.
Founded: 2016
Oguzhan Atay, PhD Co-Founder and CEO |
David Tsao, PhD Co-Founder and CTO |
Nipun Soni CFO |
Gary Palmer, MD Chief Medical Officer, Oncology |